Spyglass Pharma Funding & Investors
SpyGlass Pharma was Co-founded by Dr. Malik Y. Kahook, MD and Glenn Sussman. The company is focused on the development of novel treatments for chronic ophthalmic diseases based on technology originally developed in the Sue Anschutz-Rodgers Eye Center of the University of Colorado School of Medicine.
spyglasspharma.comTotal Amount Raised: $109,782,352
Spyglass Pharma Funding Rounds
Series C
$90,000,000
Series C Investors
Ra Capital ManagementVensana CapitalSamsara BioCapitalNew Enterprise Associates (NEA)Vertex Ventures HCSeries Unknown
$13,749,996
Series Unknown
$6,032,351
Funding info provided by Diffbot.